PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel DeviceGlobeNewsWire • 05/25/21
Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics' EsoCheck and EsoGuard TechnologiesGlobeNewsWire • 05/24/21
PAVmed Inc. (PAVM) CEO Lishan Aklog on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/18/21
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021GlobeNewsWire • 05/13/21
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics' Board of DirectorsGlobeNewsWire • 04/29/21
PAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO by Healthcare Technology ReportGlobeNewsWire • 04/15/21
PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual ConferenceGlobeNewsWire • 03/10/21
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of DirectorsGlobeNewsWire • 03/01/21
PAVmed's (PAVM) CEO Lishan Aklog on Business Update and Preliminary Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/22/21
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial ResultsGlobeNewsWire • 02/22/21
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM ESTGlobeNewsWire • 02/18/21
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed's CarpX® DeviceGlobeNewsWire • 02/16/21